A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
Clinical trial NCT06199466 · TERMINATED
Trial details
- NCT number
- NCT06199466
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2025-09-15
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.